|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.384 USD | -1.54% |
|
+2.05% | -30.18% |
| 05-20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
| 05-15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Nuo Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 0.234577 million compared to USD 0.0611 million a year ago. Net loss was USD 0.708781 million compared to USD 0.855755 million a year ago.
Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.18% | 17.59M | |
| +16.53% | 122B | |
| +20.16% | 115B | |
| +21.22% | 26.64B | |
| -23.52% | 19.91B | |
| -17.47% | 16.32B | |
| -45.95% | 15.52B | |
| -18.70% | 15.49B | |
| +61.85% | 14.83B | |
| +2.82% | 13.67B |
NUO THERAPEUTICS, INC. 
